Lung Disease and FLNA Mutations

ConditionEmphysema
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity Hospital, Lille

About this trial

Some sparse scientific data support the hypothesis that otherwise unexplained emphysema may be associated with FLNA variants. This transversal multicentric study aimed to describe the frequency of emphysema in patients carrying an FLNA variation. Patients with FLNA variations who accept the study will benefit from a chest physician's clinical examination, respiratory function tests, a cardiac ultrasound and a chest scan. The primary endpoint is to describe emphysema's frequency in patients carrying FLNA variation. The other objectives are to describe emphysema's features in these patients, the prevalence of pulmonary hypertension and to describe their lung function abnormalities. The final goal is to confirm the association between unexplained emphysema and FLNA mutation.

Eligibility criteria

Qualifiers

Patient with an FLNA mutation (or gene alteration)

Patient who has given written consent to participate in the trial

Socially insured patient

Patient willing to comply with all study procedures and duration

Disqualifiers

Patient refused or unable to give informed consent

Administrative reasons: inability to receive information, inability to participate in the entire study, lack of coverage by the social security system,

Pregnant or breastfeeding women

Patient under guardianship

Trial design

Treatments tested in this trial

  • Radiation: Chest HRCT

Treatment groups

70 Participants
are divided into 1 treatment group

Sponsors and collaborators